These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 36835442)

  • 21. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture.
    Danese PN; Pratt LA; Kolter R
    J Bacteriol; 2000 Jun; 182(12):3593-6. PubMed ID: 10852895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Exopolysaccharides in Oral Biofilms.
    Cugini C; Shanmugam M; Landge N; Ramasubbu N
    J Dent Res; 2019 Jul; 98(7):739-745. PubMed ID: 31009580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing biofilm management through nanoformulation strategies: a review of dosage forms and administration routes.
    Simsekli O; Bilinmis I; Celik S; Arık G; Baba AY; Karakucuk A
    J Drug Target; 2023 Dec; 31(9):931-949. PubMed ID: 37831630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-assembling diphenylalanine peptide nanotubes selectively eradicate bacterial biofilm infection.
    Porter SL; Coulter SM; Pentlavalli S; Thompson TP; Laverty G
    Acta Biomater; 2018 Sep; 77():96-105. PubMed ID: 30031161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. aBiofilm: a resource of anti-biofilm agents and their potential implications in targeting antibiotic drug resistance.
    Rajput A; Thakur A; Sharma S; Kumar M
    Nucleic Acids Res; 2018 Jan; 46(D1):D894-D900. PubMed ID: 29156005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of extracellular polysaccharides, secreted by Lactobacillus plantarum and Bacillus spp., as reducing indole production agents to control biofilm formation and efflux pumps inhibitor in Escherichia coli.
    Mahdhi A; Leban N; Chakroun I; Bayar S; Mahdouani K; Majdoub H; Kouidhi B
    Microb Pathog; 2018 Dec; 125():448-453. PubMed ID: 30316009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biofilm inhibition/eradication: exploring strategies and confronting challenges in combatting biofilm.
    Srivastava A; Verma N; Kumar V; Apoorva P; Agarwal V
    Arch Microbiol; 2024 Apr; 206(5):212. PubMed ID: 38616221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm.
    Kim D; Liu Y; Benhamou RI; Sanchez H; Simón-Soro Á; Li Y; Hwang G; Fridman M; Andes DR; Koo H
    ISME J; 2018 Jun; 12(6):1427-1442. PubMed ID: 29670217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanocarriers for combating biofilms: Advantages and challenges.
    Zhang Y; Lin S; Fu J; Zhang W; Shu G; Lin J; Li H; Xu F; Tang H; Peng G; Zhao L; Chen S; Fu H
    J Appl Microbiol; 2022 Sep; 133(3):1273-1287. PubMed ID: 35621701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida albicans biofilms produce antifungal-tolerant persister cells.
    LaFleur MD; Kumamoto CA; Lewis K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhamnose Binding Protein as an Anti-Bacterial Agent-Targeting Biofilm of
    Fu TK; Ng SK; Chen YE; Lee YC; Demeter F; Herczeg M; Borbás A; Chiu CH; Lan CY; Chen CL; Chang MD
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31207891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal Biofilm Strategies: A Less Explored Area in Wound Management.
    Bharti S; Zakir F; Mirza MA; Aggarwal G
    Curr Pharm Biotechnol; 2022; 23(12):1497-1513. PubMed ID: 35410595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
    van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
    Tiwari V; Tiwari D; Patel V; Tiwari M
    Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofilms and antimicrobial resistance.
    Patel R
    Clin Orthop Relat Res; 2005 Aug; (437):41-7. PubMed ID: 16056024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exopolysaccharides and Biofilms.
    Le Mauff F
    Curr Top Microbiol Immunol; 2020; 425():225-254. PubMed ID: 32072265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroform extract of turmeric inhibits biofilm formation, EPS production and motility in antibiotic resistant bacteria.
    Hayat S; Sabri AN; McHugh TD
    J Gen Appl Microbiol; 2018 Jan; 63(6):325-338. PubMed ID: 29142162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients' Central Venous Catheters.
    Liu F; Hansra S; Crockford G; Köster W; Allan BJ; Blondeau JM; Lainesse C; White AP
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial extracellular polysaccharides involved in biofilm formation.
    Vu B; Chen M; Crawford RJ; Ivanova EP
    Molecules; 2009 Jul; 14(7):2535-54. PubMed ID: 19633622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments.
    Singh S; Datta S; Narayanan KB; Rajnish KN
    J Genet Eng Biotechnol; 2021 Sep; 19(1):140. PubMed ID: 34557983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.